文献速递头颈外科

18FDG-PET/CT检测头颈癌患者同步恶性肿瘤的系统评价与Meta分析

Efficacy of 18FDG-PET/CT in Detecting Synchronous Malignancies in Patients With Head and Neck Cancer: A Systematic Review and Meta-analysis.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-06-29

该系统评价与Meta分析纳入17项研究、4624例初治头颈鳞状细胞癌患者,评估18FDG-PET/CT检测第二原发恶性肿瘤的诊断准确性,汇总灵敏度0.73、特异度0.99,不同解剖部位表现不一,食管第二原发肿瘤灵敏度较低。

要点

  • 18FDG-PET/CT检测第二原发恶性肿瘤汇总灵敏度0.73(95%CI 0.49-0.88),特异度0.99(95%CI 0.98-1.00)。
  • 食管第二原发肿瘤灵敏度0.47(95%CI 0.30-0.64)、特异度0.99(95%CI 0.98-1.00)。
  • 头颈第二原发肿瘤灵敏度0.86(95%CI 0.73-0.94);肺第二原发肿瘤灵敏度0.92(95%CI 0.84-0.96)。

核心结论

  • 本研究结果提示18FDG-PET/CT在头颈鳞状细胞癌初始检查中检测第二原发恶性肿瘤的准确性不一,凸显了对高危患者采用食管镜等筛查手段的重要性。

研究设计与样本

  • 系统评价与Meta分析,检索Medline、Embase、Cochrane Library和Scopus(1946年至2022年12月)。
  • 最终纳入17项研究、4624例初治头颈鳞状细胞癌患者,共475个第二原发恶性肿瘤。
  • 采用双变量随机效应模型Meta分析和多变量Meta回归建模,参照病理组织学、研究期间临床随访及其他影像学模态作为参考标准。

主要发现

  • 18FDG-PET/CT检测第二原发恶性肿瘤的汇总灵敏度为0.73(95%CI 0.49-0.88),汇总特异度为0.99(95%CI 0.98-1.00)。
  • 食管第二原发肿瘤的灵敏度和特异度分别为0.47(95%CI 0.30-0.64)和0.99(95%CI 0.98-1.00)。
  • 头颈第二原发肿瘤的灵敏度和特异度分别为0.86(95%CI 0.73-0.94)和0.99(95%CI 0.98-1.00)。
  • 肺第二原发肿瘤的灵敏度和特异度分别为0.92(95%CI 0.84-0.96)和0.99(95%CI 0.98-1.00)。
  • 11项研究为低偏倚风险,其余为高偏倚风险类别。

临床怎么用

  • 作者认为,18FDG-PET/CT在头颈鳞状细胞癌初始检查中检测第二原发恶性肿瘤的准确性不一,凸显了对高危患者采用食管镜等筛查手段的重要性。

局限性

  • 17项研究中11项为低偏倚风险,其余为高偏倚风险类别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the diagnostic accuracy of fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography (18FDG-PET/CT) in detecting second primary malignancies (SPMs) in patients with treatment naïve head and neck squamous cell carcinoma (HNSCC). DATA SOURCES: Medline, Embase, Cochrane Library, and Scopus searched from 1946 to December 2022. REVIEW METHODS: Studies reporting the performance of 18FDG-PET/CT in patients with treatment-naïve, index HNSCC for detection of SPMs were included. The reference standard was histopathology, clinical follow-up over the duration of study, and other imaging modalities. Multiple investigators completed depth full-text analysis. Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines were followed. Methodologic and diagnostic accuracy data were abstracted independently by multiple investigators. Risk of bias assessment was conducted using the Quality Assessment of Diagnostic Accuracy Studies tool independently. Bivariate random-effects model meta-analysis and multivariable meta-regression modeling were used. RESULTS: Seventeen studies examining 4624 patients with a total of 475 SPMs were included in the final analysis. Eleven studies were found to be at low risk for bias, while the rest were in the high-risk category. 18FDG-PET/CT demonstrated pooled sensitivity and specificity of 0.73 (95% confidence interval [CI]: 0.49-0.88) and 0.99 (95% CI: 0.98-1.00) in detecting SPMs. Further subsite analysis revealed varied diagnostic performance across different anatomical regions, with sensitivity and specificity of esophageal SPMs being 0.47 (0.30-0.64) and 0.99 (0.98-1.00), and sensitivity and specificity of 0.86 (0.73-0.94) and 0.99 (0.98-1.00) for head and neck SPMs. Finally, this imaging modality showed sensitivity and specificity of 0.92 (0.84-0.96) and 0.99 (0.98-1.00) for lung SPMs. CONCLUSION: The findings of this study suggest varied accuracy of 18FDG-PET/CT in detecting SPMs during initial workup for HNSCC, highlighting the importance of screening modalities such as esophagoscopy in high-risk patients.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Ershadifar S, Larsson J, Young K, et al. Efficacy of 18FDG-PET/CT in Detecting Synchronous Malignancies in Patients With Head and Neck Cancer: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg. 2024. PMID: 38943453. doi:10.1002/ohn.879

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。